About this document
Revisiting IL-1 Inhibitors in Osteoarthritis by ferifhrans is a document available to read on EtoBox.
This review discusses the potential role of interleukin-1 (IL-1) inhibitors in treating osteoarthritis (OA), highlighting the unmet need for effective therapies and the disappointing results of previous clinical trials targeting IL-1. Despite negative outcomes, post-hoc analyses from cardiovascular studies suggest that IL-1 inhibition may benefit certain OA patients, particularly those with a metabolic phenotype. The authors argue for a reevaluation of IL-1
- Author
- ferifhrans
- Language
- EN